233 related articles for article (PubMed ID: 37439165)
1. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis
Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165
[TBL] [Abstract][Full Text] [Related]
2. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
[TBL] [Abstract][Full Text] [Related]
3. [Acetylcorynoline relieves 2, 4, 6-trinitrobenesulfonic acid-induced Crohn's disease-like colitis in mice by regulating intestinal epithelial cell apoptosis].
Li Q; Huang J; Sun Y; Xu Y; Wang L; Zhang X; Wang Y; Geng Z; Song X; Zuo L; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1306-1314. PubMed ID: 37712266
[TBL] [Abstract][Full Text] [Related]
4. Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling.
Li Q; Li J; Yin L; Huang J; Liu X; Shi J; Geng Z; Song X; Wang L; Wang Y; Zhang X; Zuo L; Hu J
Int Immunopharmacol; 2024 Apr; 131():111886. PubMed ID: 38493691
[TBL] [Abstract][Full Text] [Related]
5. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway.
Zhang M; Song X; Liu S; Zhang N; Yang M; Gao P; Geng Z; Zuo L; Zhang X; Wang L; Wang Y; Li J; Hu J
Int Immunopharmacol; 2024 Jun; 134():112181. PubMed ID: 38733829
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and experimental verification reveal the mechanism of Hedysari Radix and Curcumae Rhizoma with the optimal compatibility ratio against colitis-associated colorectal cancer.
Zhang Y; Wang Y; Xin E; Zhang Z; Ma D; Liu T; Gao F; Bian T; Sun Y; Wang M; Wang Z; Yan X; Li Y
J Ethnopharmacol; 2024 Mar; 322():117555. PubMed ID: 38110130
[TBL] [Abstract][Full Text] [Related]
7. [Protective effect of procyanidin B2 on intestinal barrier and against enteritis in a mouse model of trinitrobenzene sulphonic acid-induced colitis].
Jiang C; Zhu P; Shi Y; Xiang W; Ge S; Zhang Z; Zuo L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jul; 39(7):778-783. PubMed ID: 31340909
[TBL] [Abstract][Full Text] [Related]
8. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling.
Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L
Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
10. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling.
Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J
Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862
[TBL] [Abstract][Full Text] [Related]
11. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study.
Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L
EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187
[TBL] [Abstract][Full Text] [Related]
12. [Prunetin inhibits TLR4/MyD88 pathway to attenuate intestinal epithelial inflammatory response and ameliorate mouse Crohn's disease-like colitis].
Li J; Sun Y; Xiong X; Wang M; Zuo L; Wang Y; Geng Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):199-206. PubMed ID: 38512029
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
15. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway.
Li C; Wang L; Zhao J; Wei Y; Zhai S; Tan M; Guan K; Huang Z; Chen C
Phytomedicine; 2022 Sep; 104():154284. PubMed ID: 35777121
[TBL] [Abstract][Full Text] [Related]
16. [Anti-inflammatory mechanism of
Zhang Y; Tu X; Zhang Y; Wen D; Zhao F; Yuan L; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):383-392. PubMed ID: 37087582
[TBL] [Abstract][Full Text] [Related]
17. [Upregulating KLF11 ameliorates intestinal inflammation in mice with 2, 4, 6-trinitrobenesulfonic acid-induced colitis by inhibiting the JAK2/STAT3 signaling pathway].
Xi J; Zhang M; Zhang Y; Zhang C; Zhang Y; Wang R; Shen L; Li J; Song X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):765-772. PubMed ID: 38708511
[TBL] [Abstract][Full Text] [Related]
18. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
Yao L; Chen X; Shen M; Zhao Y; Cao Q
Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the potential mechanisms of Amomi fructus against gastric ulcers via integrating network pharmacology and in vivo experiments.
Lv Y; Li J; Li Y; Su J; Ding X; Yuan Y; Liu S; Mou Y; Li G; Zhang L
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117179. PubMed ID: 37777029
[TBL] [Abstract][Full Text] [Related]
20. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier.
Zhang X; Zhang F; Li Y; Fan N; Zhao K; Zhang A; Kang J; Lin Y; Xue X; Jiang X
J Transl Med; 2024 Apr; 22(1):406. PubMed ID: 38689349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
